{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:34:12Z","timestamp":1793597652826,"version":"4.5.0"},"reference-count":176,"publisher":"Portland Press Ltd.","issue":"8","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dengue, caused by dengue virus (DENV), is now endemic in nearly 100 countries and infection incidence is reported in another 30 countries. Yearly an estimated 400 million cases and 2200 deaths are reported. Effective vaccines against DENV are limited and there has been significant focus on the development of effective antiviral against the disease. The World Health Organization has initiated research programs to prioritize the development and optimization of antiviral agents against several viruses including Flaviviridae. A significant effort has been taken by the researchers to develop effective antivirals against DENV. Several potential small-molecule inhibitors like efavirenz, tipranavir and dasabuvir have been tested against envelope and non-structural proteins of DENV, and are in clinical trials around the world. We recently developed one small molecule, namely 7D, targeting the host PF4-CXCR3 axis. 7D inhibited all 4 serotypes of DENV in vitro and specifically DENV2 infection in two different mice models. Although the development of dengue vaccines remains a high priority, antibody cross reactivity among the serotypes and resulting antibody-dependent enhancement (ADE) of infection are major concerns that have limited the development of effective vaccine against DENV. Therefore, there has been a significant emphasis on the development of antiviral drugs against dengue. This review article describes the rescue effects of some of the small molecule inhibitors to viral\/host factors associated with DENV pathogenesis.<\/jats:p>","DOI":"10.1042\/bsr20240134","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:27:47Z","timestamp":1721903267000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Dengue virus: pathogenesis and potential for small molecule inhibitors"],"prefix":"10.1042","volume":"44","author":[{"given":"Navya","family":"Chauhan","sequence":"first","affiliation":[{"name":"Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan\u00a0Kumar","family":"Gaur","sequence":"additional","affiliation":[{"name":"Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejeswara\u00a0Rao","family":"Asuru","sequence":"additional","affiliation":[{"name":"Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-6692","authenticated-orcid":false,"given":"Prasenjit","family":"Guchhait","sequence":"additional","affiliation":[{"name":"Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"2024081407111493200_B1","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3390\/v14112575","article-title":"Immune-mediated pathogenesis in dengue virus infection","volume":"14","author":"Khanam","year":"2022","journal-title":"Viruses"},{"key":"2024081407111493200_B2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1139\/cjm-2020-0572","article-title":"Dengue virus: epidemiology, biology, and disease aetiology","volume":"67","author":"Roy","year":"2021","journal-title":"Can. J. Microbiol."},{"key":"2024081407111493200_B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00284-020-02284-w","article-title":"Current understanding of the pathogenesis of dengue virus infection","volume":"78","author":"Bhatt","year":"2021","journal-title":"Curr. Microbiol."},{"key":"2024081407111493200_B4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/v9060137","article-title":"The 5\u02b9 and 3\u02b9 untranslated regions of the flaviviral genome","volume":"9","author":"Ng","year":"2017","journal-title":"Viruses"},{"key":"2024081407111493200_B5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/v16010045","article-title":"Anti-dengue: a machine learning-assisted prediction of small molecule antivirals against dengue virus and implications in drug repurposing","volume":"16","author":"Gautam","year":"2024","journal-title":"Viruses"},{"key":"2024081407111493200_B6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1248\/cpb.c17-00794","article-title":"Dengue virus and its inhibitors: a brief review","volume":"66","author":"Tian","year":"2018","journal-title":"Chem. Pharm. Bull."},{"key":"2024081407111493200_B7","doi-asserted-by":"publisher","first-page":"199018","DOI":"10.1016\/j.virusres.2022.199018","article-title":"Dengue virus infection - a review of pathogenesis, vaccines, diagnosis and therapy","volume":"324","author":"Kok","year":"2023","journal-title":"Virus Res."},{"key":"2024081407111493200_B8","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.1093\/nar\/gkx1127","article-title":"NS3 helicase from dengue virus specifically recognizes viral RNA sequence to ensure optimal replication","volume":"45","author":"Swarbrick","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2024081407111493200_B9","doi-asserted-by":"publisher","first-page":"e0007894","DOI":"10.1371\/journal.pntd.0007894","article-title":"Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase","volume":"13","author":"Shimizu","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2024081407111493200_B10","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.1128\/JVI.00365-14","article-title":"Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor D4 and downstream mitogen-activated protein kinase signaling","volume":"88","author":"Smith","year":"2014","journal-title":"J. Virol."},{"key":"2024081407111493200_B11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol"},{"key":"2024081407111493200_B12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"2024081407111493200_B13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/microorganisms8060891","article-title":"Roles of macrophage migration inhibitory factor in dengue pathogenesis: From pathogenic factor to therapeutic target","volume":"8","author":"Lai","year":"2020","journal-title":"Microorganisms"},{"key":"2024081407111493200_B14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/tropicalmed6040180","article-title":"Current trends and limitations in dengue antiviral research","volume":"6","author":"Obi","year":"2021","journal-title":"Tropical Med. Infectious Dis."},{"key":"2024081407111493200_B15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.antiviral.2009.12.011","article-title":"Strategies for development of dengue virus inhibitors","volume":"85","author":"Noble","year":"2010","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B16","doi-asserted-by":"publisher","first-page":"111628","DOI":"10.1016\/j.ejmech.2019.111628","article-title":"De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus","volume":"182","author":"Leal","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"2024081407111493200_B17","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1128\/JVI.05468-11","article-title":"Inhibition of dengue virus by targeting viral NS4B protein","volume":"85","author":"Xie","year":"2011","journal-title":"J. Virol."},{"key":"2024081407111493200_B18","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","article-title":"Small molecule inhibitors that selectively block dengue virus methyltransferase","volume":"286","author":"Lim","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"16","key":"2024081407111493200_B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-015-0248-x","article-title":"A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture","volume":"12","author":"Raut","year":"2015","journal-title":"Virol. J."},{"key":"2024081407111493200_B20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.antiviral.2013.03.023","article-title":"Small molecule inhibitors of ER \u03b1-glucosidases are active against multiple hemorrhagic fever viruses","volume":"98","author":"Chang","year":"2013","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/CMR.00035-09","article-title":"Dengue virus pathogenesis: An integrated view","volume":"22","author":"Martina","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"2024081407111493200_B23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.virol.2008.03.028","article-title":"Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever","volume":"376","author":"Durbin","year":"2008","journal-title":"Virology"},{"key":"2024081407111493200_B24","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2174\/138945006779025383","article-title":"Dengue virus RNA polymerase NS5: a potential therapeutic target?","volume":"7","author":"Rawlinson","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"2024081407111493200_B25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus Res."},{"key":"2024081407111493200_B26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/17460441.2020.1811675","article-title":"An update on dengue vaccine development, challenges, and future perspectives","volume":"16","author":"Idris","year":"2021","journal-title":"Expert Opin. Drug Discovery"},{"key":"2024081407111493200_B27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3181\/0707-MR-198","article-title":"Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)\/dengue shock syndrome (DSS) in dengue virus infection","volume":"233","author":"Noisakran","year":"2008","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"2024081407111493200_B28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/microorganisms8040599","article-title":"FDA-approved drugs efavirenz, tipranavir, and dasabuvir inhibit replication of multiple flaviviruses in vero cells","volume":"8","author":"Stefanik","year":"2020","journal-title":"Microorganisms"},{"key":"2024081407111493200_B29","first-page":"1171","article-title":"Drugs for dengue: A patent review (2010-2014). Expert Opinion on Therapeutic Patents","volume":"24","author":"Beesetti","year":"2014","journal-title":"Informa Healthcare"},{"key":"2024081407111493200_B30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1061937","article-title":"Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: in silico vs. in vitro approach","volume":"13","author":"Norshidah","year":"2023","journal-title":"Front. Cell. Infection Microbiol."},{"key":"2024081407111493200_B31","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1128\/JVI.00632-13","article-title":"The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase","volume":"87","author":"de Wispelaere","year":"2013","journal-title":"J. Virol."},{"key":"2024081407111493200_B32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"2024081407111493200_B33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ebiom.2018.11.049","article-title":"Platelet factor 4 promotes rapid replication and propagation of Dengue and Japanese encephalitis viruses","volume":"39","author":"Ojha","year":"2019","journal-title":"EBioMedicine"},{"key":"2024081407111493200_B34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-981-10-8727-1_22","article-title":"Dengue antiviral development: a continuing journey","volume":"1062","author":"Low","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"2024081407111493200_B35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: Dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2024081407111493200_B36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coviro.2020.07.009","article-title":"Recent advances in antiviral drug development towards dengue virus","volume":"43","author":"Troost","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"2024081407111493200_B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69515-9","article-title":"Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production","volume":"10","author":"Songprakhon","year":"2020","journal-title":"Sci. Rep."},{"key":"2024081407111493200_B38","doi-asserted-by":"publisher","DOI":"10.3390\/v13020308","article-title":"Honeysuckle aqueous extracts induced let-7a suppress ev71 replication and pathogenesis in vitro and in vivo and is predicted to inhibit sars-cov-2","volume":"13","author":"Lee","year":"2021","journal-title":"Viruses"},{"key":"2024081407111493200_B39","doi-asserted-by":"publisher","first-page":"251482","DOI":"10.1155\/2012\/251482","article-title":"Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells","volume":"2012","author":"Rothan","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"2024081407111493200_B40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1471-2334-12-314","article-title":"Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1","volume":"12","author":"Rothan","year":"2012","journal-title":"BMC Infectious Diseases"},{"key":"2024081407111493200_B41","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: New prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"2024081407111493200_B42","doi-asserted-by":"publisher","first-page":"8873","DOI":"10.1074\/jbc.M609919200","article-title":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner","volume":"282","author":"Miller","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2024081407111493200_B43","doi-asserted-by":"publisher","first-page":"14333","DOI":"10.1073\/pnas.2335168100","article-title":"Inhibition of interferon signaling by dengue virus","volume":"100","author":"Mu\u00f1 Oz-Jord\u00e1","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2024081407111493200_B44","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1128\/AAC.02462-15","article-title":"Escape mutations in NS4B render dengue virus insensitive to the antiviral activity of the paracetamol metabolite AM404","volume":"60","author":"van Cleef","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B45","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1128\/JVI.00855-15","article-title":"Discovery of dengue virus NS4B inhibitors","volume":"89","author":"Wang","year":"2015","journal-title":"J. Virol."},{"key":"2024081407111493200_B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1004682","article-title":"A crystal structure of the dengue virus NS5 protein reveals a novel inter-domain interface essential for protein flexibility and virus replication","volume":"11","author":"Zhao","year":"2015","journal-title":"PLoS Pathog."},{"key":"2024081407111493200_B47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1128\/JVI.00047-17","article-title":"Interactions between the dengue virus polymerase ns5 and stem-loop a genome replication and regulation of viral gene expression crossm","volume":"91","author":"Bujalowski","year":"2017","journal-title":"J. Virol."},{"key":"2024081407111493200_B48","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.3390\/molecules26113118","article-title":"Cordycepin inhibits virus replication in dengue virus-infected vero cells","volume":"26","author":"Panya","year":"2021","journal-title":"Molecules"},{"key":"2024081407111493200_B49","first-page":"250","article-title":"Phytochemical Study of Myrtopsis corymbosa, Perspectives for Anti-Dengue Natural Compound Research","volume":"7","author":"Coulerie","year":"2013","journal-title":"Nat. Prod"},{"key":"2024081407111493200_B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002627","article-title":"Small-molecule inhibitors of dengue-virus entry","volume":"8","author":"Schmidt","year":"2012","journal-title":"PLoS Pathog."},{"key":"2024081407111493200_B51","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.antiviral.2009.09.011","article-title":"A small molecule fusion inhibitor of dengue virus","volume":"84","author":"Poh","year":"2009","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000428","article-title":"Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors","volume":"2","author":"Yang","year":"2007","journal-title":"PloS ONE"},{"key":"2024081407111493200_B53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","article-title":"In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses","volume":"84","author":"Kampmann","year":"2009","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B54","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/AAC.01148-08","article-title":"A small-molecule dengue virus entry inhibitor","volume":"53","author":"Wang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B55","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/cb800176t","article-title":"Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein","volume":"3","author":"Zhou","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"2024081407111493200_B56","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cbdd.12309","article-title":"Peptide inhibitors against dengue virus infection","volume":"84","author":"Panya","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"2024081407111493200_B57","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-019-1127-7","article-title":"Efficacy of geraniin on dengue virus type-2 infected BALB\/c mice","volume":"16","author":"Abdul Ahmad","year":"2019","journal-title":"Virol. J."},{"key":"2024081407111493200_B58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12985-017-0895-1","article-title":"Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication","volume":"14","author":"Abdul Ahmad","year":"2017","journal-title":"Virol. J."},{"key":"2024081407111493200_B59","doi-asserted-by":"publisher","first-page":"719","DOI":"10.7150\/ijms.5037","article-title":"Inhibition of dengue virus entry into target cells using synthetic antiviral peptides","volume":"10","author":"Alhoot","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"2024081407111493200_B60","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cbdd.12576","article-title":"A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) Protein with activity against dengue virus infection","volume":"86","author":"Panya","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"2024081407111493200_B61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2018.04.019","article-title":"Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions","volume":"155","author":"Smith","year":"2018","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.antiviral.2011.12.003","article-title":"Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors","volume":"93","author":"Tomlinson","year":"2012","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B63","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B64","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","article-title":"Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format","volume":"453","author":"Basavannacharya","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2024081407111493200_B65","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1021\/id5000458","article-title":"Benzothiazole and pyrrolone flavivirus inhibitors targeting the viral helicase","volume":"1","author":"Sweeney","year":"2015","journal-title":"ACS Infectious Dis."},{"key":"2024081407111493200_B66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.antiviral.2012.08.006","article-title":"Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation","volume":"96","author":"Ndjomou","year":"2012","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B67","doi-asserted-by":"publisher","first-page":"85938","DOI":"10.1039\/C5RA14469H","article-title":"Reaching beyond HIV\/HCV: Nelfinavir as a potential starting point for broad-spectrum protease inhibitors against dengue and chikungunya virus","volume":"5","author":"Bhakat","year":"2015","journal-title":"RSC Adv."},{"key":"2024081407111493200_B68","doi-asserted-by":"publisher","DOI":"10.1002\/psc.3196","article-title":"Carnosine exhibits significant antiviral activity against Dengue and Zika virus","volume":"25","author":"Rothan","year":"2019","journal-title":"J. Pept. Sci."},{"key":"2024081407111493200_B69","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00705-010-0702-4","article-title":"Identification of palmatine as an inhibitor of West Nile virus","volume":"155","author":"Jia","year":"2010","journal-title":"Arch. Virol"},{"key":"2024081407111493200_B70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.antiviral.2012.02.008","article-title":"Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease","volume":"94","author":"Nitsche","year":"2012","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B71","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1016\/j.bmc.2011.05.015","article-title":"Synthesis and biological evaluation of \u03b1-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture","volume":"19","author":"Steuer","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"2024081407111493200_B72","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ab.2009.08.013","article-title":"A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease","volume":"395","author":"Bodenreider","year":"2009","journal-title":"Anal. Biochem."},{"key":"2024081407111493200_B73","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3851\/IMP1767","article-title":"Small molecule pan-dengue and West Nile virus NS3 protease inhibitors","volume":"21","author":"Cregar-Hernandez","year":"2011","journal-title":"Antivir. Chem. Chemother."},{"key":"2024081407111493200_B74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.antiviral.2009.02.190","article-title":"Structure-based discovery of dengue virus protease inhibitors","volume":"82","author":"Tomlinson","year":"2009","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B75","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bmc.2012.10.058","article-title":"Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)- one and 1,3,4-oxadiazole hybrid derivatives: Potent inhibitors of Dengue and West Nile virus NS2B\/NS3 proteases","volume":"21","author":"Lai","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"2024081407111493200_B76","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1128\/AAC.03543-14","article-title":"Novel dengue virus NS2B\/NS3 protease inhibitors","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2016.08.014","article-title":"High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease","volume":"134","author":"Balasubramanian","year":"2016","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbrc.2013.09.078","article-title":"A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication","volume":"440","author":"Pambudi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2024081407111493200_B79","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","article-title":"Discovery of nanomolar dengue and west nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue","volume":"58","author":"Behnam","year":"2015","journal-title":"J. Med. Chem."},{"key":"2024081407111493200_B80","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2180-14-140","article-title":"Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus","volume":"14","author":"Rothan","year":"2014","journal-title":"BMC Microbiol."},{"key":"2024081407111493200_B81","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1128\/AAC.01281-13","article-title":"A novel dengue virus inhibitor, BP13944, discovered by high-Throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B\/NS3 protease","volume":"58","author":"Yang","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B82","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/aps.2015.56","article-title":"Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"2024081407111493200_B83","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/AAC.00855-10","article-title":"Novel dengue virus-specific NS2B\/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay","volume":"55","author":"Yang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B84","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1021\/acs.jmedchem.5b00612","article-title":"Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors","volume":"58","author":"Weigel","year":"2015","journal-title":"J. Med. Chem."},{"key":"2024081407111493200_B85","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/cbdd.12500","article-title":"Structure-guided discovery of a novel non-peptide inhibitor of dengue virus NS2B-NS3 protease","volume":"86","author":"Li","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"2024081407111493200_B86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.antiviral.2017.10.011","article-title":"Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library","volume":"147","author":"Hernandez-Morales","year":"2017","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B87","doi-asserted-by":"publisher","first-page":"eabb2181","DOI":"10.1126\/scitranslmed.abb2181","article-title":"NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models","volume":"13","author":"Moquin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"2024081407111493200_B88","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","article-title":"A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction","volume":"598","author":"Kaptein","year":"2021","journal-title":"Nature"},{"key":"2024081407111493200_B89","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.antiviral.2018.05.003","article-title":"Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A","volume":"155","author":"Nobori","year":"2018","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B90","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1021\/acs.jmedchem.5b00327","article-title":"5\u2032-silylated 3\u2032-1,2,3-triazolyl thymidine analogues as inhibitors of West Nile Virus and Dengue virus","volume":"58","author":"Vernekar","year":"2015","journal-title":"J. Med. Chem."},{"key":"2024081407111493200_B91","doi-asserted-by":"publisher","first-page":"e0130083","DOI":"10.1371\/journal.pone.0130083","article-title":"Murine efficacy and pharmacokinetic evaluation of the flaviviral NS5 capping enzyme 2-thioxothiazolidin-4-one inhibitor BG-323","volume":"10","author":"Bullard","year":"2015","journal-title":"PloS ONE"},{"key":"2024081407111493200_B92","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/acsinfecdis.5b00070","article-title":"Identification and characterization of novel broad-spectrum inhibitors of the flavivirus methyltransferase","volume":"1","author":"Brecher","year":"2016","journal-title":"ACS Infectious Dis."},{"key":"2024081407111493200_B93","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.phytochem.2012.07.023","article-title":"Antiviral chlorinated daphnane diterpenoid orthoesters from the bark and wood of Trigonostemon cherrieri","volume":"84","author":"Allard","year":"2012","journal-title":"Phytochemistry"},{"key":"2024081407111493200_B94","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1021\/np200715v","article-title":"Alkylated flavanones from the bark of cryptocarya chartacea as dengue virus NS5 polymerase inhibitors","volume":"74","author":"Allard","year":"2011","journal-title":"J. Nat. Prod."},{"key":"2024081407111493200_B95","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1055\/s-0031-1298355","article-title":"Biflavonoids of Dacrydium balansae with potent inhibitory activity on dengue 2 NS5 polymerase","volume":"78","author":"Coulerie","year":"2012","journal-title":"Planta Med."},{"key":"2024081407111493200_B96","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1021\/acsmedchemlett.9b00619","article-title":"Pyridobenzothiazolones Exert Potent Anti- Dengue Activity by Hampering Multiple Functions of NS5 Polymerase","volume":"11","author":"Cannalire","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"2024081407111493200_B97","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.fitote.2012.05.004","article-title":"Chemical constituents of Anacolosa pervilleana and their antiviral activities","volume":"83","author":"Bourjot","year":"2012","journal-title":"Fitoterapia"},{"key":"2024081407111493200_B98","doi-asserted-by":"publisher","first-page":"e01130","DOI":"10.1128\/JVI.01130-20","article-title":"Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies","volume":"94","author":"Arora","year":"2020","journal-title":"J. Virol."},{"key":"2024081407111493200_B99","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1128\/AAC.48.10.3944-3953.2004","article-title":"A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties","volume":"48","author":"Olsen","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B100","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1128\/AAC.01335-10","article-title":"INX-08189, a phosphoramidate prodrug of 6-O-methyl-2\u2032-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties","volume":"55","author":"Vernachio","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B101","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"2024081407111493200_B102","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1128\/JVI.02841-13","article-title":"Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir","volume":"88","author":"Chen","year":"2014","journal-title":"J. Virol."},{"key":"2024081407111493200_B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2015.01.002","article-title":"Characterization of the activity of 2\u2032-C-methylcytidine against dengue virus replication","volume":"116","author":"Lee","year":"2015","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B104","doi-asserted-by":"publisher","first-page":"e1005737","DOI":"10.1371\/journal.ppat.1005737","article-title":"Potent allosteric dengue virus NS5 polymerase inhibitors: mechanism of action and resistance profiling","volume":"12","author":"Lim","year":"2016","journal-title":"PLoS Pathog."},{"key":"2024081407111493200_B105","doi-asserted-by":"publisher","first-page":"116356","DOI":"10.1016\/j.bmc.2021.116356","article-title":"Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens","volume":"46","author":"Mahajan","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"2024081407111493200_B106","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3390\/ijms18091957","article-title":"Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low-density lipoprotein receptor, and DC-SIGN","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"2024081407111493200_B107","doi-asserted-by":"publisher","first-page":"e21658","DOI":"10.1371\/journal.pone.0021658","article-title":"Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells","volume":"6","author":"Alen","year":"2011","journal-title":"PloS ONE"},{"key":"2024081407111493200_B108","doi-asserted-by":"publisher","first-page":"170797","DOI":"10.1016\/j.peptides.2022.170797","article-title":"CD44 antiviral peptide as an inhibitor of the protein-protein interaction in dengue virus invasion","volume":"153","author":"Recalde-Reyes","year":"2022","journal-title":"Peptides"},{"key":"2024081407111493200_B109","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.antiviral.2019.05.004","article-title":"Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545","volume":"168","author":"Modhiran","year":"2019","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B110","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1128\/AAC.00620-11","article-title":"A translation inhibitor that suppresses dengue virus in vitro and in vivo","volume":"55","author":"Wang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B111","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3851\/IMP1884","article-title":"Narasin, a novel antiviral compound that blocks dengue virus protein expression","volume":"16","author":"Low","year":"2011","journal-title":"Antivir. Ther."},{"key":"2024081407111493200_B112","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2016.02.005","article-title":"Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses","volume":"128","author":"Carocci","year":"2016","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B113","doi-asserted-by":"publisher","first-page":"104589","DOI":"10.1016\/j.antiviral.2019.104589","article-title":"Antiviral activity of ST081006 against the dengue virus","volume":"171","author":"Lee","year":"2019","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B114","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.antiviral.2016.04.014","article-title":"Novel antiviral activity of bromocriptine against dengue virus replication","volume":"131","author":"Kato","year":"2016","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B115","article-title":"c-Src protein kinase inhibitors block assembly and maturation of dengue virus","volume":"104","author":"Chu","year":"2006","journal-title":"Harvard Medical School"},{"key":"2024081407111493200_B116","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1128\/JVI.79.14.8698-8706.2005","article-title":"Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo","volume":"79","author":"Whitby","year":"2005","journal-title":"J. Virol."},{"key":"2024081407111493200_B117","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-017-0072-7","article-title":"Identification of novel antiviral fungus-derived brefeldin A against dengue viruses","volume":"45","author":"Raekiansyah","year":"2017","journal-title":"Tropical Med. Health"},{"key":"2024081407111493200_B118","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbrc.2008.08.100","article-title":"Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga","volume":"376","author":"Hidari","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2024081407111493200_B119","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.antiviral.2005.08.006","article-title":"Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses","volume":"69","author":"Lee","year":"2006","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B120","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.antiviral.2005.02.001","article-title":"The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell","volume":"66","author":"Talarico","year":"2005","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B121","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.antiviral.2008.05.007","article-title":"In vitro inhibition of dengue polysaccharides against dengue virus is dependent on virus serotype and host cell. chemistries","volume":"80","author":"Rees","year":"2008","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B122","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ijbiomac.2012.05.028","article-title":"Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides","volume":"51","author":"Pujol","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"2024081407111493200_B123","doi-asserted-by":"publisher","first-page":"e2188","DOI":"10.1371\/journal.pntd.0002188","article-title":"Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry\/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application","volume":"7","author":"Ichiyama","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2024081407111493200_B124","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.antiviral.2010.09.002","article-title":"Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein","volume":"88","author":"Kato","year":"2010","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B125","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.antiviral.2018.04.018","article-title":"Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with \u03b23 integrin","volume":"155","author":"Cui","year":"2018","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B126","first-page":"168","article-title":"The animal models for dengue virus infection","volume":"28","author":"Peng","year":"2004","journal-title":"Dengue Bulletin"},{"key":"2024081407111493200_B127","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ame2.12145","article-title":"A murine model of dengue virus infection in suckling C57BL\/6 and BALB\/c mice","volume":"4","author":"Byrne","year":"2021","journal-title":"Animal Models Exp. Med."},{"key":"2024081407111493200_B128","doi-asserted-by":"publisher","DOI":"10.3390\/v12111261","article-title":"Use of animal models in studying roles of antibodies and their secretion cells in dengue vaccine development","volume":"12","author":"Chokephaibulkit","year":"2020","journal-title":"Viruses"},{"key":"2024081407111493200_B129","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1128\/JVI.03453-14","article-title":"Characterization of dengue virus NS4A and NS4B protein interaction","volume":"89","author":"Zou","year":"2015","journal-title":"J. Virol."},{"key":"2024081407111493200_B130","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/v4010062","article-title":"Animal models of dengue virus infection","volume":"4","author":"Zompi","year":"2012","journal-title":"Viruses"},{"key":"2024081407111493200_B131","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2014.00151","article-title":"Mouse models to study dengue virus immunology and pathogenesis","volume":"5","author":"Zellweger","year":"2014","journal-title":"Front. Immunol."},{"key":"2024081407111493200_B132","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00705-021-05298-2","article-title":"Mammalian animal models for dengue virus infection: a recent overview","volume":"167","author":"Kayesh","year":"2022","journal-title":"Arch. Virol"},{"key":"2024081407111493200_B133","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7774\/cevr.2017.6.2.104","article-title":"Animal models for dengue vaccine development and testing","volume":"6","author":"Na","year":"2017","journal-title":"Clin. Exp. Vaccine Res."},{"key":"2024081407111493200_B134","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/17460441.2022.2033205","article-title":"Murine models of dengue virus infection for novel drug discovery","volume":"17","author":"Byrne","year":"2022","journal-title":"Expert Opin. Drug Discovery"},{"key":"2024081407111493200_B135","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J. Virol."},{"key":"2024081407111493200_B136","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1086\/511310","article-title":"A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J. Infect. Dis."},{"key":"2024081407111493200_B137","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2009-09-242990","article-title":"Dengue virus-induced hemorrhage in a nonhuman primate model","volume":"115","author":"Onlamoon","year":"2010","journal-title":"Blood"},{"key":"2024081407111493200_B138","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41577-018-0005-7","article-title":"Nonhuman primate models of human viral infections","volume":"18","author":"Estes","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"2024081407111493200_B139","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.virol.2014.01.015","article-title":"Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis","volume":"452-453","author":"Althouse","year":"2014","journal-title":"Virology"},{"key":"2024081407111493200_B140","first-page":"1","article-title":"Non-human primate models of dengue virus infection: A comparison of viremia levels and antibody responses during primary and secondary infection among old world and new world monkeys","volume":"9","author":"Azami","year":"2020","journal-title":"Pathogens"},{"key":"2024081407111493200_B141","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4269\/ajtmh.19-0633","article-title":"Virological and immunological outcomes in rhesus monkeys after exposure to dengue virus-infected aedes aegypti mosquitoes","volume":"103","author":"Carrington","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2024081407111493200_B142","doi-asserted-by":"publisher","first-page":"e00440","DOI":"10.1128\/JVI.00440-18","article-title":"Improvement of the Dengue Virus (DENV) nonhuman primate model via a reverse translational approach based on dengue vaccine clinical efficacy data against DENV-2 and-4","volume":"92","author":"Barban","year":"2018","journal-title":"J. Virol."},{"key":"2024081407111493200_B143","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/infdis\/jiu061","article-title":"Dengue human infection model: introduction","author":"Cassetti","year":"2014","journal-title":"J. Infect. Dis."},{"key":"2024081407111493200_B144","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fmicb.2013.00305","article-title":"Can non-human primates serve as models for investigating dengue disease pathogenesis?","volume":"4","author":"Clark","year":"2013","journal-title":"Front. Microbiol."},{"key":"2024081407111493200_B145","doi-asserted-by":"publisher","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog."},{"key":"2024081407111493200_B146","doi-asserted-by":"publisher","first-page":"e0007894","DOI":"10.1371\/journal.pntd.0007894","article-title":"Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase","volume":"13","author":"Shimizu","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2024081407111493200_B147","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/v13081641","article-title":"Tree shrew as an emerging small animal model for human viral infection: A recent overview","volume":"13","author":"Kayesh","year":"2021","journal-title":"Viruses"},{"key":"2024081407111493200_B148","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1016\/j.vaccine.2010.04.045","article-title":"Report of an NIAID workshop on dengue animal models","volume":"28","author":"Cassetti","year":"2010","journal-title":"Vaccine"},{"key":"2024081407111493200_B149","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1021\/acsinfecdis.8b00054","article-title":"Preclinical antiviral testing for dengue virus infection in mouse models and its association with clinical studies","volume":"4","author":"Watanabe","year":"2018","journal-title":"ACS Infectious Dis."},{"key":"2024081407111493200_B150","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1016\/j.vaccine.2015.09.101","article-title":"Preclinical and clinical development of a dengue recombinant subunit vaccine","volume":"33","author":"Manoff","year":"2015","journal-title":"Vaccine"},{"key":"2024081407111493200_B151","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3390\/v15030705","article-title":"Molecular Mechanisms of Antiviral Agents against Dengue Virus","volume":"15","author":"Lee","year":"2023","journal-title":"Viruses"},{"key":"2024081407111493200_B152","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2017.11.009","article-title":"The antimicrobial peptide HS-1 inhibits dengue virus infection","volume":"514","author":"Monteiro","year":"2018","journal-title":"Virology"},{"key":"2024081407111493200_B153","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1038\/s41598-023-29517-9","article-title":"Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro","volume":"13","author":"Radoshitzky","year":"2023","journal-title":"Sci. Rep."},{"key":"2024081407111493200_B154","doi-asserted-by":"publisher","first-page":"104899","DOI":"10.1016\/j.antiviral.2020.104899","article-title":"Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses","volume":"182","author":"Konkolova","year":"2020","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B155","article-title":"Drug repurposing approaches to fight Dengue virus infection and related diseases","author":"Botta","year":"1996"},{"key":"2024081407111493200_B156","doi-asserted-by":"publisher","first-page":"700502","DOI":"10.3389\/fcimb.2021.700502","article-title":"Combination treatment with remdesivir and ivermectin exerts highly synergistic and potent antiviral activity against murine coronavirus infection","volume":"11","author":"Tan","year":"2021","journal-title":"Front. Cell. Infection Microbiol."},{"key":"2024081407111493200_B157","doi-asserted-by":"publisher","first-page":"e0006934","DOI":"10.1371\/journal.pntd.0006934","article-title":"Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus","volume":"12","author":"Xu","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2024081407111493200_B158","doi-asserted-by":"publisher","first-page":"E586","DOI":"10.1093\/cid\/ciaa1332","article-title":"Ivermectin accelerates circulating nonstructural protein 1 (NS1) clearance in adult dengue patients: a combined phase 2\/3 randomized double-blinded placebo controlled trial","volume":"72","author":"Suputtamongkol","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"2024081407111493200_B159","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S1473-3099(23)00782-X","article-title":"Dengue control, if not by vaccination and vector strategies, then possibly by therapeutics","volume":"24","author":"Niranjan","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"2024081407111493200_B160","doi-asserted-by":"publisher","first-page":"e0144123","DOI":"10.1128\/mbio.01441-23","article-title":"Dengue virus NS1 secretion is regulated via importin-subunit \u03b21 controlling expression of the chaperone GRp78 and targeted by the clinical drug ivermectin","volume":"14","author":"Denolly","year":"2023","journal-title":"MBio"},{"key":"2024081407111493200_B161","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40506-023-00263-w","article-title":"Dengue: update on clinically relevant therapeutic strategies and vaccines","volume":"15","author":"Palanichamy Kala","year":"2023","journal-title":"Curr. Treatment Options Infectious Dis."},{"key":"2024081407111493200_B162","doi-asserted-by":"publisher","first-page":"e1006673","DOI":"10.1371\/journal.ppat.1006673","article-title":"Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components","volume":"13","author":"Glasner","year":"2017","journal-title":"PLoS Pathog."},{"key":"2024081407111493200_B163","doi-asserted-by":"publisher","first-page":"e0006715","DOI":"10.1371\/journal.pntd.0006715","article-title":"The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR","volume":"12","author":"Kao","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2024081407111493200_B164","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.1038\/s41598-019-45095-1","article-title":"Neutralization of acidic intracellular vesicles by niclosamide inhibits multiple steps of the dengue virus life cycle in vitro","volume":"9","author":"Jung","year":"2019","journal-title":"Sci. Rep."},{"key":"2024081407111493200_B165","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1021\/acsinfecdis.0c00052","article-title":"Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential","volume":"6","author":"Xu","year":"2020","journal-title":"ACS Infectious Dis."},{"key":"2024081407111493200_B166","doi-asserted-by":"publisher","first-page":"105495","DOI":"10.1016\/j.antiviral.2022.105495","article-title":"A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships","volume":"210","author":"Goethals","year":"2023","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B167","doi-asserted-by":"publisher","first-page":"e0098821","DOI":"10.1128\/AAC.00988-21","article-title":"Evaluation of AT-752, a double prodrug of a guanosine nucleotide analog with in vitro and in vivo activity against dengue and other flaviviruses","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B168","doi-asserted-by":"publisher","first-page":"e0161523","DOI":"10.1128\/aac.01615-23","article-title":"First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus","volume":"68","author":"Zhou","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024081407111493200_B169","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/v13050771","article-title":"Antiviral evaluation of uv-4b and interferon-alpha combination regimens against dengue virus","volume":"13","author":"Franco","year":"2021","journal-title":"Viruses"},{"key":"2024081407111493200_B170","doi-asserted-by":"publisher","first-page":"e0006421","DOI":"10.1371\/journal.pntd.0006421","article-title":"Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis","volume":"12","author":"Qiu","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2024081407111493200_B171","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in Adult dengue patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J. Infect. Dis."},{"key":"2024081407111493200_B172","doi-asserted-by":"publisher","first-page":"e0004851","DOI":"10.1371\/journal.pntd.0004851","article-title":"Extended evaluation of virological, immunological and pharmacokinetic endpoints of CELADEN: a randomized, placebo-controlled trial of celgosivir in dengue fever patients","volume":"10","author":"Sung","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2024081407111493200_B173","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2012.02.006","article-title":"The 1\u03b1,25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytes","volume":"94","author":"Puerta-Guardo","year":"2012","journal-title":"Antiviral Res."},{"key":"2024081407111493200_B174","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijid.2020.11.115","article-title":"Knowledge and attitude of community members and health care workers on Lassa fever during an outbreak in Kogi State, Nigeria 2016","volume":"101","author":"Ejembi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"2024081407111493200_B175","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1099\/vir.0.007914-0","article-title":"A role for autophagolysosomes in dengue virus 3 production in HepG2 cells","volume":"90","author":"Khakpoor","year":"2009","journal-title":"J. Gen. Virol."},{"key":"2024081407111493200_B176","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3390\/v15102012","article-title":"Novel potent autophagy inhibitor Ka-003 inhibits dengue virus replication","volume":"15","author":"Limthongkul","year":"2023","journal-title":"Viruses"}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20240134\/959890\/bsr-2024-0134c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20240134\/959890\/bsr-2024-0134c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T03:12:25Z","timestamp":1723605145000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/44\/8\/BSR20240134\/234730\/Dengue-virus-pathogenesis-and-potential-for-small"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":176,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,28]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20240134","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,8]]},"article-number":"BSR20240134"}}